Hepatocyte growth factor inhibits anoikis of pancreatic carcinoma cells through phosphatidylinositol 3-kinase pathway

Pancreas

Volumn 40, Issue 4, 2011, Pages 608-614

  Watanabe, Satoshi ^a   Kishimoto, Takashi ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

anoikis; apoptosis; E cadherin; hepatocyte growth factor; pancreatic carcinoma; phosphatidylinositol 3 kinase

Indexed keywords

CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCATTER FACTOR; SYNAPTOPHYSIN; UVOMORULIN;

ANOIKIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CARCINOMA CELL; CELL ADHESION; CELL AGGREGATION; CELL CONTACT; CELL INTERACTION; CELL PROLIFERATION; CODON; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE MUTATION; HUMAN; METASTASIS; PANCREAS CARCINOMA; PHOSPHORYLATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANDROSTADIENES; ANIMALS; ANOIKIS; ANTIBODIES; BLOTTING, WESTERN; CADHERINS; CELL ADHESION; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ENZYME INHIBITORS; HEPATOCYTE GROWTH FACTOR; HUMANS; IMIDAZOLES; MICE; MICE, INBRED BALB C; MICE, NUDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PANCREATIC NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PYRIDINES; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79955073106     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318214fa6c     Document Type: Article

References (37)

1. Van den Broeck A, Sergeant G, Ectors N, et al. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2009; 35:600-604.
2. Westerdahl J, Andrén-Sandberg A, Ihse I. Recurrence of exocrine pancreatic cancer - local or hepatic? Hepatogastroenterology. 1993; 40:384-387. (Pubitemid 23258561)
3. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994; 124:619-626. (Pubitemid 24064472)
4. Cao L, Han L, Zhang Z, et al. Involvement of anoikis-resistance in the metastasis of hepatoma cells. Exp Cell Res. 2009; 315:1148-1156.
5. Zhu Z, Sanchez-Sweatman O, Huang X, et al. Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res. 2001; 61:1707-1716. (Pubitemid 34292609)
6. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989; 342:440-443. (Pubitemid 19277521)
7. Jin H, Yang R, Zheng Z, et al. MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival. Cancer Res. 2008; 68:4360-4368.
8. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991; 251:802-804. (Pubitemid 21926175)
9. Jeffers M, Rong S, Woude GF. Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med. 1996; 74:505-513. (Pubitemid 26306792)
10. Kiehne K, Herzig KH, Fölsch UR. c-Met expression in pancreatic cancer and effects of hepatocyte growth factor on pancreatic cancer cell growth. Pancreas. 1997; 15:35-40. (Pubitemid 27527357)
11. Furukawa T, Duguid WP, Kobari M, et al. Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis. Am J Pathol. 1995; 147:889-895.
12. Bauer TW, Somcio RJ, Fan F, et al. Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells. Mol Cancer Ther. 2006; 5:1676-1682. (Pubitemid 44323235)
13. Ebert M, Yokoyama M, Friess H, et al. Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res. 1994; 54:5775-5778. (Pubitemid 24375202)
14. Matsushita A, Götze T, Korc M. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Cancer Res. 2007; 67:10309-10316. (Pubitemid 350070805)
15. Murakami M, Nagai E, Mizumoto K, et al. Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice. Int J Cancer. 2005; 117:160-165. (Pubitemid 41262770)
16. Zeng Q, McCauley LK, Wang CY. Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma J Biol Chem. 2002; 277:50137-50142. (Pubitemid 36014467)
17. Kanayama S, Yamada Y, Kawaguchi R, et al. Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells. Oncol Rep. 2008; 19:117-122. (Pubitemid 351176139)
18. Kishimoto T, Ishikura H, Kimura C, et al. Phenotypes correlating to metastatic properties of pancreas adenocarcinoma in vivo: the importance of surface sialyl Lewis(a) antigen. Int J Cancer. 1996; 69:290-294. (Pubitemid 26298293)
19. Takeuchi M, Shichinohe T, Senmaru N, et al. The dominant negative H-ras mutant, N116Y, suppresses growth of metastatic human pancreatic cancer cells in the liver of nude mice. Gene Ther. 2000; 7:518-526. (Pubitemid 30156567)
20. Kantak SS, Kramer RH. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem. 1998; 273:16953-16961. (Pubitemid 28311727)
21. Kang HG, Jenabi JM, Zhang J, et al. E-cadherin cell-cell adhesion in Ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res. 2007; 67:3094-3105. (Pubitemid 46724846)
22. Bergin E, Levine JS, Koh JS, et al. Mouse proximal tubular cell-cell adhesion inhibits apoptosis by a cadherin-dependent mechanism. Am J Physiol Renal Physiol. 2000; 278:758-768.
23. Dorudi S, Sheffield JP, Poulsom R, et al. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol. 1993; 142:981-986. (Pubitemid 24060573)
24. Pignatelli M, Ansari TW, Gunter P, et al. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol. 1994; 174:243-248.
25. von Burstin J, Eser S, Paul MC, et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/ HDAC2 repressor complex. Gastroenterology. 2009; 137:361-371.
26. Burdsal CA, Damsky CH, Pedersen RA. The role of E-cadherin and integrins in mesoderm differentiation and migration at the mammalian primitive streak. Development. 1993; 118:829-844. (Pubitemid 23232790)
27. Kabashima A, Higuchi H, Takaishi H, et al. Side population of pancreatic cancer cells predominates in TGF-A-mediated epithelial to mesenchymal transition and invasion. Int J Cancer. 2009; 124:2771-2779.
28. Satoh K, Hamada S, Kimura K, et al. Up-regulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells. Am J Pathol. 2008; 172:926-939. (Pubitemid 351519990)
29. Edderkaoui M, Hong P, Lee JK, et al. Insulin-like growth factor-I receptor mediates the prosurvival effect of fibronectin. J Biol Chem. 2007; 282:26646-26655. (Pubitemid 47501963)
30. Douma S, Van Laar T, Zevenhoven J, et al. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature. 2004; 430:1034-1039.
31. Graziani A, Gramaglia D, dalla Zonca P, et al. Hepatocyte growth factor/scatter factor stimulates the Ras-guanine nucleotide exchanger. J Biol Chem. 1993; 268:9165-9168. (Pubitemid 23145952)
32. Graziani A, Gramaglia D, Cantley LC, et al. The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. J Biol Chem. 1991; 266:22087-22090. (Pubitemid 21908617)
33. Zeng Q, Chen S, You Z, et al. Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFJB. J Biol Chem. 2002; 277:25203-25208. (Pubitemid 34951827)
34. Agbunag C, Bar-Sagi D. Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells. Cancer Res. 2004; 64:5659-5663. (Pubitemid 39095562)
35. Takeda A, Osaki M, Adachi K, et al. Role of the phosphatidylinositol 3'-kinase-Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines. Pancreas. 2004; 28:353-358. (Pubitemid 38437337)
36. Semba S, Moriya T, Kimura W, et al. Phosphorylated Akt/PKB controls cell growth and apoptosis in intraductal papillary-mucinous tumor and invasive ductal adenocarcinoma of the pancreas. Pancreas. 2003; 26:250-257. (Pubitemid 36384157)
37. Orford K, Orford CC, Byers SW. Exogenous expression of A-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J Cell Biol. 1999; 146:855-868.